Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen V Frye

Showing results (61-70 of 126) with videos related to

Pageof 13
Sort By:
ACS Medicinal Chemistry Letters|December 21, 2016
Design and Synthesis of Novel Macrocyclic Mer Tyrosine Kinase InhibitorsXiaodong Wang, Jing Liu, Weihe Zhang, et al.
Cancers|December 23, 2022
Therapeutic Targeting of MERTK and BCL-2 in T-Cell and Early T-Precursor Acute Lymphoblastic LeukemiaRyan J Summers, Juhi Jain, Eleana Vasileiadi, et al.
ACS Chemical Biology|May 9, 2020
Discovery and Characterization of Peptide Inhibitors for Calcium and Integrin Binding Protein 1Ana C Puhl, Jonathan W Bogart, Victoria A Haberman, et al.
Molecules (Basel, Switzerland)|February 27, 2020
Design and Construction of a Focused DNA-Encoded Library for Multivalent Chromatin Reader ProteinsJustin M Rectenwald, Shiva Krishna Reddy Guduru, Zhao Dang, et al.
Molecular Cancer Therapeutics|November 29, 2018
Inhibition of MERTK Promotes Suppression of Tumor Growth in BRAF Mutant and BRAF Wild-Type MelanomaLenka Sinik, Katherine A Minson, John J Tentler, et al.
Cancer Research|January 31, 2015
Tumor Endothelial Cells with Distinct Patterns of TGFβ-Driven Endothelial-to-Mesenchymal TransitionLin Xiao, Dae Joong Kim, Clayton L Davis, et al.
JCI Insight|December 3, 2020
MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunityAlisa B Lee-Sherick, Kristen M Jacobsen, Curtis J Henry, et al.
JCI Insight|November 3, 2018
MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunityAlisa B Lee-Sherick, Kristen M Jacobsen, Curtis J Henry, et al.
Journal of Medicinal Chemistry|July 18, 2014
Discovery of a selective, substrate-competitive inhibitor of the lysine methyltransferase SETD8Anqi Ma, Wenyu Yu, Fengling Li, et al.
ACS Chemical Biology|March 6, 2023
PROTAC Linkerology Leads to an Optimized Bivalent Chemical Degrader of Polycomb Repressive Complex 2 (PRC2) ComponentsFrances M Bashore, Caroline A Foley, Han Wee Ong, et al.
Pageof 13

Showing results (61-70 of 126) with videos related to

Sort By:
Pageof 13
ACS Medicinal Chemistry Letters|December 21, 2016
Design and Synthesis of Novel Macrocyclic Mer Tyrosine Kinase InhibitorsXiaodong Wang, Jing Liu, Weihe Zhang, et al.
Cancers|December 23, 2022
Therapeutic Targeting of MERTK and BCL-2 in T-Cell and Early T-Precursor Acute Lymphoblastic LeukemiaRyan J Summers, Juhi Jain, Eleana Vasileiadi, et al.
ACS Chemical Biology|May 9, 2020
Discovery and Characterization of Peptide Inhibitors for Calcium and Integrin Binding Protein 1Ana C Puhl, Jonathan W Bogart, Victoria A Haberman, et al.
Molecules (Basel, Switzerland)|February 27, 2020
Design and Construction of a Focused DNA-Encoded Library for Multivalent Chromatin Reader ProteinsJustin M Rectenwald, Shiva Krishna Reddy Guduru, Zhao Dang, et al.
Molecular Cancer Therapeutics|November 29, 2018
Inhibition of MERTK Promotes Suppression of Tumor Growth in BRAF Mutant and BRAF Wild-Type MelanomaLenka Sinik, Katherine A Minson, John J Tentler, et al.
Cancer Research|January 31, 2015
Tumor Endothelial Cells with Distinct Patterns of TGFβ-Driven Endothelial-to-Mesenchymal TransitionLin Xiao, Dae Joong Kim, Clayton L Davis, et al.
JCI Insight|December 3, 2020
MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunityAlisa B Lee-Sherick, Kristen M Jacobsen, Curtis J Henry, et al.
JCI Insight|November 3, 2018
MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunityAlisa B Lee-Sherick, Kristen M Jacobsen, Curtis J Henry, et al.
Journal of Medicinal Chemistry|July 18, 2014
Discovery of a selective, substrate-competitive inhibitor of the lysine methyltransferase SETD8Anqi Ma, Wenyu Yu, Fengling Li, et al.
ACS Chemical Biology|March 6, 2023
PROTAC Linkerology Leads to an Optimized Bivalent Chemical Degrader of Polycomb Repressive Complex 2 (PRC2) ComponentsFrances M Bashore, Caroline A Foley, Han Wee Ong, et al.
Pageof 13